Mervin  Smith net worth and biography

Mervin Smith Biography and Net Worth

EVP of Business Operations of iRhythm Technologies

Merv Smith has served as Executive Vice President of Business Operations since July 2023. In addition to other responsibilities, Merv oversees our Global Business Services center, Clinical Operations, Manufacturing and Business Operations. Prior to iRhythm, Merv served in executive leadership roles at Zimmer Biomet, a global medical technology company, where he spent 20 years building and leading teams that propelled operational excellence while owning global sales, commercial channels, and full P&L responsibilities across several organizations. In his last four years there, Merv served as Vice President & General Manager for Surgical, Restorative Therapies & Office Based Technologies.

Mr. Smith holds a Master of Business Administration (MBA) from Ball State University and a Bachelor of Science, Accounting, from the University of Pittsburgh. Merv has also completed Stanford Biodesign’s executive education program, ‘Managing Innovation from the Inside Out’, which provides executives with a fresh perspective on how to drive innovation within their organizations.

What is Mervin Smith's net worth?

The estimated net worth of Mervin Smith is at least $763,946.40 as of August 2nd, 2024. Mr. Smith owns 10,360 shares of iRhythm Technologies stock worth more than $763,946 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Smith may own. Learn More about Mervin Smith's net worth.

How old is Mervin Smith?

Mr. Smith is currently 49 years old. There are 7 older executives and no younger executives at iRhythm Technologies. The oldest executive at iRhythm Technologies is Mr. Marc Rosenbaum, Senior VP of Finance & Chief Accounting Officer, who is 52 years old. Learn More on Mervin Smith's age.

How do I contact Mervin Smith?

The corporate mailing address for Mr. Smith and other iRhythm Technologies executives is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. iRhythm Technologies can also be reached via phone at (415) 632-5700 and via email at [email protected]. Learn More on Mervin Smith's contact information.

Has Mervin Smith been buying or selling shares of iRhythm Technologies?

Mervin Smith has not been actively trading shares of iRhythm Technologies during the last quarter. Most recently, Mervin Smith sold 688 shares of the business's stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $74.66, for a transaction totalling $51,366.08. Following the completion of the sale, the executive vice president now directly owns 10,360 shares of the company's stock, valued at $773,477.60. Learn More on Mervin Smith's trading history.

Who are iRhythm Technologies' active insiders?

iRhythm Technologies' insider roster includes C. Bairey Merz (Director), Quentin Blackford (CEO), Mark Day (EVP), Douglas Devine (CFO), Patrick Murphy (EVP), Chad Patterson (Chief Commercial Officer), Sumi Shrishrimal (EVP, Chief Risk Officer), Mervin Smith (EVP of Business Operations), Minang Turakhia (Chief Medical Officer, Chief Scientific Officer and EVP, Product Innovation), David Vort (EVP), and Daniel Wilson (EVP). Learn More on iRhythm Technologies' active insiders.

Are insiders buying or selling shares of iRhythm Technologies?

In the last year, iRhythm Technologies insiders bought shares 2 times. They purchased a total of 6,944 shares worth more than $521,860.64. In the last year, insiders at the sold shares 12 times. They sold a total of 66,532 shares worth more than $6,937,400.34. The most recent insider tranaction occured on November, 4th when Director Abhijit Y Talwalkar bought 6,664 shares worth more than $500,866.24. Insiders at iRhythm Technologies own 0.7% of the company. Learn More about insider trades at iRhythm Technologies.

Information on this page was last updated on 11/4/2024.

Mervin Smith Insider Trading History at iRhythm Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/2/2024Sell688$74.66$51,366.0810,360View SEC Filing Icon  
See Full Table

Mervin Smith Buying and Selling Activity at iRhythm Technologies

This chart shows Mervin Smith's buying and selling at iRhythm Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

iRhythm Technologies Company Overview

iRhythm Technologies logo
iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $73.74
Low: $72.36
High: $75.15

50 Day Range

MA: $72.82
Low: $57.07
High: $89.50

2 Week Range

Now: $73.74
Low: $55.92
High: $124.11

Volume

558,042 shs

Average Volume

613,413 shs

Market Capitalization

$2.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23